Table: Shin Nippon Biomedical - 6-MTH group results

Shin Nippon Biomedical Laboratories

08/11/2019 06:00

Nov 8 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2019        Sep 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             6.39                8.88             14.47    
                 (-28.1 pct)         (+17.6 pct)      (-7.6 pct)  
  Operating         1.08            loss 137 mln          1.80    
                                                     (+116.9 pct) 
  Recurring         1.26               885 mln            2.00    
                 (+42.1 pct)                          (+23.9 pct) 
  Net              877 mln             912 mln            1.40    
                 (-3.8 pct)                           (-28.2 pct) 
  EPS             21.07 yen           21.91 yen        33.62 yen  
  Ann Div                             3.00 yen         5.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             3.00 yen         5.00 yen   
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T